The Office of Texas Attorney General Ken Paxton announced a lawsuit against Pfizer, Tris Pharma, and Tris CEO Ketan Mehta for “defrauding the Texas Medicaid program by providing adulterated pharmaceutical drugs to Texas children in violation of the Texas Medicaid Fraud Prevention Act, now known as the Texas Health Care Program Fraud Prevention Act (‘THFPA’).”
“Pfizer contracted with Tris, a drug manufacturer, to produce a pediatric attention-deficit/hyperactivity disorder medication (‘ADHD’), Quillivant XR. Pfizer knowingly distributed Quillivant to children on Medicaid despite the drug’s pattern of failing quality control tests due to flawed manufacturing practices. For years, Tris altered the drug’s testing method in violation of federal and state laws to ensure Quillivant passed regulatory hurdles and could continue to be sold,” a press release read.
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!